Cannabis Oil for a Child's Epilepsy: One Scottish Family's Story

Facebook ↗WhatsApp ↗

Originally published 2020-03-27.

Scottish Mother Says Cannabis Oil Stopped Her Son’s Seizures

Lisa Quarrell, a former police officer from Scotland, told The Scottish Sun that cannabis oil transformed the life of her seven-year-old son, Cole Thomson. Cole had been having up to 20 seizures a day from a form of epilepsy that affected one side of his brain. Medicines and surgery had not controlled it. After nearly ten months on a cannabis oil called Bedrolite, his mother said, he had become almost entirely seizure-free.

Her account is powerful, and it reflects what a number of UK families have reported. It is also one child's story, and it sits inside a complicated picture of law, cost and medical evidence. Here is what happened, what cannabis-based medicines can and cannot do for epilepsy, and what families should know.

Cole's story

According to his mother, Cole's seizures came on hard. Before the cannabis oil, the attacks were so frequent that ordinary life became almost impossible. She described the change bluntly: "Cole went from a normal wee boy riding his bike to being in a wheelchair." He lost his speech and, at his worst, could not lift his head.

His epilepsy involved one hemisphere of his brain and had not responded to standard anti-seizure drugs. An operation intended to help also failed. Quarrell said she feared he could be left paralysed, and began looking at cannabis oil, which some parents in the UK were by then obtaining from abroad.

Within weeks of starting it, she reported, his seizures fell sharply. In time he was back playing football with other children. "He is sharper, and he's aware of everything that is going on now," she said.

What Bedrolite is

Bedrolite is a Dutch-made medicinal cannabis product. It is described as rich in cannabidiol (CBD) and very low in tetrahydrocannabinol (THC), the compound that produces a "high". The label visible in the photo above shows a 10 ml bottle prescribed for Cole by name with a measured dose.

Because it contains some THC, Bedrolite is a controlled drug in the UK. Quarrell said she was initially warned she could face prosecution for bringing cannabis oil into Scotland, but no charges followed. She later found a legal route to import it from the Netherlands on prescription, at a reported cost of about £800 a month for five 10 ml bottles.

The law on medical cannabis in Scotland and the UK

Drug law is set at UK level, so the same rules apply in Scotland, England, Wales and Northern Ireland. Recreational cannabis remains illegal and is a Class B drug.

On 1 November 2018, after high-profile cases involving two boys with severe epilepsy, Billy Caldwell and Alfie Dingley, the UK government moved cannabis-based products for medicinal use into Schedule 2. That made it legal for specialist doctors to prescribe them for patients with an exceptional clinical need.

In practice, NHS prescriptions have remained rare. The NHS funds cannabis-based medicines mainly for rare, severe forms of epilepsy, nausea caused by chemotherapy and spasticity in multiple sclerosis. Many families have turned to private clinics instead, where costs can run to hundreds or even thousands of pounds a month; one family reported paying £2,000 a month for their daughter. Quarrell campaigned for Cole to receive Bedrolite through the NHS, saying: "It seems so unfair that we've found something that works, but we're being told we can't have it."

What the research says about cannabis and epilepsy

The strongest evidence concerns purified CBD rather than whole-plant oils. A pharmaceutical-grade CBD medicine called Epidiolex (Epidyolex in Europe) was approved by the US Food and Drug Administration in 2018 for seizures linked to two severe childhood epilepsies, Lennox-Gastaut syndrome and Dravet syndrome. Tuberous sclerosis complex was added in 2020. In the EU it is approved alongside the drug clobazam for the first two conditions, and it can be prescribed on the NHS for these rare epilepsies.

For other kinds of epilepsy, and for whole-plant products containing THC, good-quality trial evidence is much thinner. Many reports, like Cole's, are encouraging but come from individual families. A single case cannot show what caused an improvement: seizures can change with age, with other medicine changes or for reasons nobody can identify.

CBD medicines also have side effects. The most common include sleepiness, tiredness, diarrhoea and reduced appetite. They can affect the liver and interact with other anti-seizure drugs, including clobazam, which is why doctors monitor patients on them.

Common myths about cannabis oil

"Natural means safe." Cannabis compounds are active drugs. They can cause side effects and interact with other medicines, just like prescription tablets.

"Shop-bought CBD oil is the same thing." It is not. Investigations by the FDA found that most CBD products on sale were not accurately labelled; in one 2017 analysis, 69% were mislabelled, and in a 2020 study of 147 products about half contained THC. Doses in unregulated products can be far higher or lower than stated.

"Cannabis cures epilepsy." Cannabis-based medicines can reduce seizures for some people with certain conditions. They are not a cure, and they do not work for everyone.

"One success story proves it works." Personal stories matter, and they often push research forward. Deciding whether a treatment works for a group of patients still needs careful studies.

What families can do

If your child has epilepsy that is not well controlled, talk to a doctor, ideally a paediatric neurologist. Ask whether your child's type of epilepsy is one for which licensed cannabis-based medicine is an option, whether a referral to a specialist epilepsy centre makes sense, and what other treatments, such as different medicines, diets or surgery, might be worth considering.

Please do not start, stop or change seizure medicines or add cannabis products without your child's medical team. Doing so can make seizures worse.

Lisa Quarrell's experience shows how far a parent will go for a child, and why so many families have pushed for better access. It also shows why that access needs to come with proper medical supervision, reliable products and fair funding, so that treatment does not depend on whether a family can pay hundreds of pounds a month.

Sources: Lisa Quarrell's interview with The Scottish Sun, as reported at the time; Wikipedia: Medical cannabis in the United Kingdom; Wikipedia: Cannabidiol.

COMMENTS